Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer.
In 71 patients with classic invasive ductal carcinomas, levels of prothymosin alpha (PT alpha), as assayed by a radioimmunoassay that detects thymosin alpha 1 (the NH2-terminal fragment of PT alpha), were significantly greater in tumour samples than in normal breast tissue. PT alpha levels were correlated with (a) the number of positive axillary lymph nodes (rs = 0.5384, P < 0.01), and (b) the percentage of tumour cells in the S or G2/M phase as assessed by flow cytometry (rs = 0.5027, P < 0.01). Since the beginning of this study in 1989, 21 patients have presented distant metastases, all of whom were previously shown to have tumour PT alpha levels greater than 124 ng of thymosin alpha 1/mg protein. The present report indicates that PT alpha might be used to identify breast cancer patients at high risk for distant metastases.
Departamento de Fisiologia, Hospital Xeral de Galicia, Facultad de Medicina, Santiago de Compostela, Spain.
F
F
Dominguez
C
C
Magdalena
E
E
Cancio
E
E
Roson
J
J
Paredes
L
L
Loidi
J
J
Zalvide
M
M
Fraga
J
J
Forteza
B J
BJ
Regueiro
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000737:chemistry; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D008938:Mitosis; D011379:Prognosis; D011498:Protein Precursors / Q000032:analysis*; D011863:Radioimmunoassay; D013947:Thymosin / Q000031:analogs & derivatives* / Q000032:analysis
D011498:Protein Precursors; C040782:prothymosin alpha; D013947:Thymosin